InvestorInformation

Latest Annoucements

  • Schedule of Investors /Analysts’ call with Management on 09.02.2023 and Registration Log-in details for the same

    01.02.2023 Read More
  • Presentation at JP Morgan Healthcare Conference, SFO US

    10.01.2023 Read More
  • Disclosure of material event – Updates on acquisition

    22.12.2022 Read More
  • Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme

    21.12.2022 Read More
  • Press Release in relation to acquisition of ‘Razel’ franchise from Glenmark Pharmaceuticals Limited

    14.12.2022 Read More
  • Disclosure of Material Event – Acquisition

    14.12.2022 Read More
  • Disclosure of Material Event – Q2 FY 23 Earnings Call Transcript

    18.11.2022 Read More
  • Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme

    17.11.2022 Read More
  • Audio recording of earnings conference call

    15.11.2022 Read More
  • Q2 FY23 Press Release / News

    12.11.2022 Read More
  • Q2 FY23 Investor Presentation

    12.11.2022 Read More
  • Q2 FY23 Results Sheet

    12.11.2022 Read More
  • Schedule of Investors /Analysts’ call with Management on 14.11.2022 and Registration Log-in details for the same

    07.11.2022 Read More
  • Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme

    13.09.2022 Read More
  • Disclosure of Material Event – Proceedings of AGM

    25.08.2022 Read More
  • AGM Voting Results FY22-23

    25.08.2022 Read More
  • Q1 FY23 Press Release / News

    23.08.2022 Read More
  • Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme

    20.08.2022 Read More
  • Audio recording of earnings conference call

    06.08.2022 Read More
  • Grant of Options under Employee Stock Option Scheme

    04.08.2022 Read More
  • Q1 FY23 Investor Presentation

    04.08.2022 Read More
  • Q1 FY23 Results Sheet

    04.08.2022 Read More

Financial Information

Know More

Shareholder's corner

Know More

CEO's Desk

We are BIG enough to create a positive impact for patients and healthcare providers, we are small enough to still care…

Know More

IR & Shareholders Contact

For Shareholders:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com

For Transfer/Transmission of Shares:
Datamatics Business Solutions Ltd.
Plot No. B 5, Part B Crosslane,
MIDC, Andheri (East), Mumbai 400 093.
India.

Contact Person: Mr. Satish Patil
Tel No. (022) 6671 2001-06
Fax No. (022) 6671 2011
Email: corpequity@dfssl.com

Nodal Officer for the Purpose of Coordination with IEPF Authority:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg, Prabhadevi,
Mumbai 400 025.
India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com